We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




World's First Open-Source Real-Time PCR Thermocycler Launched

By LabMedica International staff writers
Posted on 16 Nov 2014
Priced at a tenth the cost of traditional cyclers, the low-cost qPCR thermocycler will especially benefit lesser-funded laboratories and can facilitate diagnostics in developing countries.

Chai Biotechnologies (Santa Clara, CA, USA), a biotech startup focused on making core molecular biological technologies more accessible while developing powerful tools for synthetic biologists, now offers Open qPCR—the world's first open-source real-time PCR thermocycler. More...
The new relative quantitative PCR (qPCR) machine has now been launched via a KickStarter crowdfunding campaign.

As with real-time PCR used in diagnostic and research applications, Open qPCR is capable of genotyping, pathogen presence/absence detection, and relative DNA quantification. With its current 16-well sample capacity (100 µL or 200 µL tubes), it is primarily focused on diagnostics related applications.

The instrument is currently available for USD 1,499 as part of the campaign, and is expected to ship in March 2015. "With Real-Time PCR thermocyclers typically costing USD 20,000 and up, this technology was simply unaffordable to lesser funded university labs, institutes in developing countries dealing with emerging epidemics, and the growing DIYbio [do-it-yourself biology] maker-movement," said Josh Perfetto, founder and chief executive of Chai, "With Open qPCR, we've lowered the cost of the Real-Time PCR reaction by an order of magnitude." CEO Perfetto was also a co-creator of the earlier OpenPCR project, which made the world's first open-source endpoint PCR thermocycler available in 2011.

Features of Open qPCR include: Visual, web-based interface for protocol editing, plate layout, and results interpretation; Integrated touch screen supports field use; Ethernet, Wi-Fi, and USB connectivity; Open API supports automation applications; Low power mode for isothermal amplification applications; Complete hardware design and software, to be released as open source when machine ships.

The KickStarter campaign runs until December 4, 2014. The campaign is also raising funds to donate instruments to Ebola clinics in western Africa.

Related Links:

Chai Biotechnologies
Open qPCR 



Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Blood Glucose Test Strip
AutoSense Test
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.